Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
about
Limitations of traditional health technology assessment methods and implications for the evaluation of novel therapies.New and emerging concepts in the use of denosumab for the treatment of osteoporosisPersistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
P2860
Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Two-year persistence and compl ...... opulation in the United States
@en
Two-year persistence and compl ...... pulation in the United States.
@nl
type
label
Two-year persistence and compl ...... opulation in the United States
@en
Two-year persistence and compl ...... pulation in the United States.
@nl
prefLabel
Two-year persistence and compl ...... opulation in the United States
@en
Two-year persistence and compl ...... pulation in the United States.
@nl
P2093
P2860
P1476
Two-year persistence and compl ...... opulation in the United States
@en
P2093
Emily Durden
Lionel Pinto
Lorena Lopez-Gonzalez
Paul Juneau
Richard Barron
P2860
P2888
P356
10.1007/S11657-017-0316-5
P407
P577
2017-02-28T00:00:00Z